SCHEMBL8039488

SCHEMBL8039488

CCCc1nn(C)c2c(=O)[nH]c(N(Cc3cccc(N4CCOCC4)c3)CC3CC4CCC3C4)nc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 19/20 0.39
HDAC1 Q13547 6/20 0.38
HDAC6 Q9UBN7 6/20 0.38
PDE6C P51160 2/20 0.38
HDAC2 Q92769 2/20 0.37
PDE3B Q13370 2/20 0.37
PDE3A Q14432 2/20 0.37
TERT O14746 1/20 0.36
PDE1A P54750 2/20 0.35
PDE1B Q01064 2/20 0.35
PDE1C Q14123 2/20 0.35
PDE2A O00408 1/20 0.35
ABCC4 O15439 1/20 0.35
ABCC5 O15440 1/20 0.35
PDE6D O43924 1/20 0.35
PDE8A O60658 1/20 0.35
PDE9A O76083 1/20 0.35
ABCB11 O95342 1/20 0.35
CYP3A4 P08684 1/20 0.35
HTR1A P08908 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4128912 0.87 PDE5A (0.41) PDE5AHDAC1HDAC6PDE6CHDAC2
SCHEMBL4136646 0.84 PDE5A (0.43) PDE5AHDAC1HDAC6PDE6CHDAC2
SCHEMBL4901618 0.84 PDE5A (0.41) PDE5AHDAC1HDAC6PDE6CHDAC2
SCHEMBL4901484 0.84 PDE5A (0.42) PDE5AHDAC1HDAC6PDE6CHDAC2
SCHEMBL4892978 0.82 PDE5A (0.45) PDE5AHDAC1HDAC6PDE6CHDAC2
SCHEMBL4905752 0.82 PDE5A (0.41) PDE5AHDAC1HDAC6PDE6CHDAC2
SCHEMBL4901853 0.82 PDE5A (0.40) PDE5AHDAC1HDAC6PDE6CHDAC2
SCHEMBL4123059 0.79 PDE5A (0.34) PDE5AHDAC1HDAC6PDE6CHDAC2
SCHEMBL4895854 0.77 PDE5A (0.45) PDE5AHDAC1HDAC6PDE6CHDAC2
SCHEMBL8037857 0.75 PDE5A (0.42) PDE5AHDAC1HDAC6PDE6CHDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071706-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed